Related Experiment Video
Updated: Apr 14, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
From biology to therapy: current standards and emerging strategies in pleural mesothelioma
J H L T van Genugten1,2, C J de Gooijer1,2, Paul Baas1,2
1Department of Thoracic Oncology, Antoni van Leeuwenhoek Hospital/Netherlands cancer Institute (AVL-NKI) - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Abstract:
Pleural mesothelioma (PM) is an aggressive malignancy with limited therapeutic options and poor long-term prognosis. Platinum-based chemotherapy has been the standard-of-care for most patients for decades. While the decoding of the genomic alterations in PM has triggered renewed interest in mesothelioma biology and targeted therapies, these have yet to reach clinical practice. The recent introduction of dual immune checkpoint blockade (ICB) with nivolumab plus ipilimumab has marked the first major advance in PM treatment for decades, yet, many patients do not respond to these drugs and durable long-term responses remain rare. A range of alternative treatment modalities are currently under clinical investigation in PM, including antibody-drug conjugates, bi-specific antibodies, chimeric antigen receptor T-cells, cancer vaccines, and oncolytic viruses. Here we review recent progress in the understanding of PM biology and evaluate relevant phase I-III clinical trials aimed at improving treatment for this disease. We also highlight ongoing and future clinical trials with promising candidates for PM therapy.
Insights
Pleural mesothelioma (PM) treatments are advancing beyond chemotherapy. While dual immune checkpoint blockade shows promise, new therapies like antibody-drug conjugates and cell-based treatments are under investigation for better outcomes in this aggressive cancer.
Area of Science:
- Oncology
- Immunotherapy
- Malignant Mesothelioma Research
Background:
- Pleural mesothelioma (PM) is an aggressive cancer with limited treatment options and poor prognosis.
- Platinum-based chemotherapy has been the long-standing standard of care.
- Despite genomic discoveries, targeted therapies for PM are not yet in clinical practice.
Purpose of the Study:
- To review recent advancements in understanding PM biology.
- To evaluate current phase I-III clinical trials for PM treatment.
- To highlight promising future therapeutic candidates for PM.
Main Methods:
- Review of recent scientific literature on PM biology.
- Analysis of ongoing and completed phase I-III clinical trials in PM.
- Identification and discussion of novel therapeutic modalities under investigation.
Main Results:
- Dual immune checkpoint blockade (ICB) with nivolumab plus ipilimumab represents a recent advance, but durable responses are infrequent.
- Many patients do not respond to current ICB therapies.
- Numerous novel treatment strategies are in clinical trials, including antibody-drug conjugates, bi-specific antibodies, CAR T-cells, vaccines, and oncolytic viruses.
Conclusions:
- Significant progress is being made in understanding PM biology and developing novel therapies.
- While ICB has improved treatment, further research is crucial for more effective and durable responses.
- Ongoing clinical trials offer hope for improved therapeutic options for pleural mesothelioma patients.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Pleura of the Lungs
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

